Literature DB >> 8485535

Some general estimation methods for nonlinear mixed-effects models.

M Davidian1, D M Giltinan.   

Abstract

A nonlinear mixed-effects model suitable for characterizing repeated measurement data is described. The model allows dependence of random coefficients on covariate information and accommodates general specifications of a common intraindividual covariance structure, such as models for variance within individuals that depend on individual mean response and autocorrelation. Two classes of procedures for estimation in this model are described, which incorporate estimation of unknown parameters in the assumed intraindividual covariance structure. The procedures are straightforward to implement using standard statistical software. The techniques are illustrated by examples in growth analysis and assay development.

Mesh:

Substances:

Year:  1993        PMID: 8485535     DOI: 10.1080/10543409308835047

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  12 in total

1.  Serial correlation in optimal design for nonlinear mixed effects models.

Authors:  Joakim Nyberg; Richard Höglund; Martin Bergstrand; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-03-14       Impact factor: 2.745

2.  Two-Stage Experimental Design for Dose-Response Modeling in Toxicology Studies.

Authors:  Kai Wang; Feng Yang; Dale W Porter; Nianqiang Wu
Journal:  ACS Sustain Chem Eng       Date:  2013-06-27       Impact factor: 8.198

3.  Treatment of batch in the detection, calibration, and quantification of immunoassays in large-scale epidemiologic studies.

Authors:  Brian W Whitcomb; Neil J Perkins; Paul S Albert; Enrique F Schisterman
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

4.  The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.

Authors:  Hanna E Silber; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-02-14       Impact factor: 2.745

5.  Practical Marginalized Multilevel Models.

Authors:  Michael E Griswold; Bruce J Swihart; Brian S Caffo; Scott L Zeger
Journal:  Stat       Date:  2013

6.  Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

Authors:  M O Karlsson; E N Jonsson; C G Wiltse; J R Wade
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

7.  Three new residual error models for population PK/PD analyses.

Authors:  M O Karlsson; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

8.  Model-Based Residual Post-Processing for Residual Model Identification.

Authors:  Moustafa M A Ibrahim; Rikard Nordgren; Maria C Kjellsson; Mats O Karlsson
Journal:  AAPS J       Date:  2018-07-02       Impact factor: 4.009

9.  A Two-Stage Estimation Method for Random Coefficient Differential Equation Models with Application to Longitudinal HIV Dynamic Data.

Authors:  Yun Fang; Hulin Wu; Li-Xing Zhu
Journal:  Stat Sin       Date:  2011-07       Impact factor: 1.261

10.  Drug disposition analysis: a comparison between budesonide and fluticasone.

Authors:  Anders Källén; Lars Thorsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.